When appropriate, surgery remains the most effective treatment option for non-small cell lung cancer (NSCLC), including for patients with COPD, said Friedberg, professor in the Department of Thoracic ...

Chronic emphysema is a type of chronic obstructive pulmonary disease (COPD) caused by damage to the air sacs in the lungs. Although there is no cure, you can manage the disease with lifestyle changes ...

Men and women with chronic obstructive pulmonary disease (COPD), bronchiectasis, and nontuberculous mycobacterial (NTM) lung disease report differences in symptoms, mental health, disease burden, and ...

Researchers at the UNC School of Medicine have developed a tool that can identify airway mucus abnormalities in patients with ...

COPD usually affects middle aged adults, and is especially prominent in those who smoke or used to smoke. It is a progressive disorder, which means that it gets worse over time. The two most common ...

Chronic obstructive pulmonary disease (COPD) is a group of syndromes which depict common general symptoms, but differ in several more detailed aspects. It is characterized by airway obstruction, ...

Temple Health is testing a tiny, flexible scaffold aimed at relieving a common problem for emphysema patients: overinflation of the lungs due to trapped air.

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Leah J. Witt, MD: ...

The National Institute for Health and Care Excellence (NICE), has published final draft guidance recommending dupilumab as a ...

The Chronic Obstructive Pulmonary Disease (COPD) Market valued at USD 13.18 billion in 2024 and is expected to reach USD 16.61 billion by 2033 with a CAGR of 2.60% during the forecast period of 2025 ...